key: cord-0957974-e2v07ww4
authors: Fadel, Francois Abi; Al-Jaghbeer, Mohammed; Kumar, Sany; Griffiths, Lori; Wang, Xiaofeng; Han, Xiaozhen; Burton, Robert
title: Clinical characteristics and outcomes of critically Ill patients with COVID-19 in Northeast Ohio: low mortality and length of stay
date: 2020-10-12
journal: Acute Crit Care
DOI: 10.4266/acc.2020.00619
sha: 3e2b2c00a862b7f2ab20fe96207f38174326cdcb
doc_id: 957974
cord_uid: e2v07ww4

BACKGROUND: Published coronavirus disease 2019 (COVID-19) reports suggest higher mortality with increasing age and comorbidities. Our study describes the clinical characteristics and outcomes for all intensive care unit (ICU) patients admitted across the Cleveland Clinic enterprise, a 10-hospital health care system in Northeast Ohio, serving more than 2.7 million people. METHODS: We analyzed the quality data registry for clinical characteristics and outcomes of all COVID-19-confirmed ICU admissions. Differences in outcomes from other health care systems and published cohorts from other parts of the world were delineated. RESULTS: Across our health care system, 495 COVID-19 patients were admitted from March 15 to June 1, 2020. Mean patient age was 67.3 years, 206 (41.6%) were females, and 289 (58.4%) were males. Mean Acute Physiology Score was 45.3, and mean Acute Physiology and Chronic Health Evaluation III score was 60.5. In total, 215 patients (43.3%) were intubated for a mean duration of 9.2 days. Mean ICU and hospital length of stay were 7.4 and 13.9 days, respectively, while mean ICU and hospital mortality rates were 18.4% and 23.8%. CONCLUSIONS: Our health care system cohort is the fourth largest to be reported. Lower ICU and hospital mortality and length of stay were seen compared to most other published reports. Better preparedness and state-level control of the surge in COVID-19 infections are likely the reasons for these better outcomes. Future research is needed to further delineate differences in mortality and length of stay across health care systems and over time.

Coronavirus disease 2019 (COVID-19) has spread across the globe, causing more than a half million deaths to date [1] . The first COVID-19 death in Ohio was reported on March 1, 2020, and it has affected more than 89,626 people up to July 31, with more than 10,678 hospitalizations and 3,442 deaths across the state [2] . Studies from different countries pointed to higher mortality with increasing age and comorbidities [3, 4] . Prior published results focused on overall hospitalized patients [3, 4] or critically ill patients [5] [6] [7] [8] [9] [10] [11] [12] [13] . Our current study describes the clinical characteristics and outcomes of all intensive care unit (ICU) patients admitted across the Cleveland Clinic enterprise, a 10-hospital health care system in Northeast Ohio with more than 60% of the market share, serving more than 2.7 million people. Through our study, we tried to explain differences in outcomes from other health care systems and published cohorts from other parts of the world.

We analyzed the Cleveland Clinic health care system quality data registry for clinical characteristics and outcomes for all COVID-19-confirmed ICU admissions from March 15 to June 1, 2020. Data were compiled on June 29 to allow a 28-day assessment of outcomes in all patients. Table 1 summarizes demographics, clinical characteristics, and outcomes data. Before finalizing this report, we gathered available preliminary outcome data as of July 25, 2020 from all 10 hospital ICU cohorts since March. COVID-19 diagnosis was based on a positive polymerase chain reaction of a nasopharyngeal swab. We collected demographics, clinical characteristics, laboratory values at admission, ICU admission sources, admission Acute Physiology Score (APS), Acute Physiology And Chronic Health Evaluation III (APACHE III) score, hospital and ICU length of stay (LOS), hospital and ICU mortality, and duration of mechanical ventilation. The Institutional Review Board at the Cleveland Clinic approved this study (No. 20-418) and waived the need for patient informed consent. A review of other published reports on critically ill patients with COVID-19, available from the United States, Canada, Italy, the United Kingdom, and China was performed, with a focus on differences in baseline characteristics and outcomes over time. Chisquare test was used for statistical analysis and comparisons of mortality and mechanical ventilator ratios. 

A review of the literature revealed several published cohorts and case series reports on demographics, clinical characteristics, and outcomes of COVID-19 patients as early as February 2020 from Wuhan, China [4] ; March 2020 from Tongji Hospital also in Wuhan, China [10] , Seattle and Washington state in the United States [6, 12] , and from the Lombardy region in Italy [5] ; May 2020 from Vancouver, Canada [8] ; a 65-center cohort study in the United States published July 2020 [7] ; and the United Kingdom's Intensive Care National Audit and Research Center report on critically ill COVID-19 patients as of July 31, 2020 [13] . Our cohort of 495 patients is the fourth largest to be reported. Median age was 68 years, with a predominantly male population at 58.4% and elevated cohort mean BMI of 31.7 kg/m 2 . These results are similar to all prior reported demographics, supporting older age, male sex, and elevated BMI as risk factors for critical illness and adverse outcomes of COVID-19 infection. Diabetic patients whether type 1 or type 2 representing 35.8% of the ICU COVID-19 population is consistent with findings from Vancouver, Canada [8] ; Seattle, WA [6] ; and Washington state [12] , as well as a multi-center cohort study across 65 centers in the United States [7] . This percentage is significantly higher than the 9.4% reported by the Center for Disease Control and Prevention Diabetes Center in Northeast Ohio, the 9.7% reported by the State of Ohio, and the 9.1% reported by the United States [15] . This confirms diabetic comorbidity to be associated with adverse outcomes including critical illness and ICU admission in COVID-19 patients.

The invasive mechanical ventilation rate in our cohort was 43.4%, similar to that reported from Wuhan, China [4, 10] . However, this result was significantly lower than all other reports of mechanical ventilator usage in critically ill patients: 63.2% in Vancouver, Canada and up to 83.9% in a multi-center cohort study of 65 centers in the United States [5] [6] [7] [8] 12, 13] (Table 1). Our reported ICU mortality of 18.4% and hospital mortality of 23.8% were significantly lower than those of most other cohorts except that from Vancouver, Canada [8] (Table 1 ). In addition, our median ICU LOS of 4.4 days was significantly shorter than that of 9 days from Lombardy, Vancouver, and Seattle [5, 8, 12] (Table 1) . When an updated outcome summary from our health care system cohort was requested on August 7, ICU mortality had decreased from 18.4% to 17% and LOS from 7.4 to 6.6 days, while hospital mortality and LOS decreased from 23.8% to 21% and from 13.9 to 12.33 days, respectively, compared to the outcome data reported at the end of June.

A recent systematic review and meta-analysis of ICU mortality in COVID-19 patients reported a 41.6% mortality rate across all studies, with no significant effect of geographical location. However, a meta-regression by month of publication revealed a significant reduction in ICU mortality over time [11] . All studies reported an ICU COVID-19 mortality higher than the 4.4% [14] to 21.4% [13] mortality reported for those with non-COVID-19 viral and community-acquired pneumonia, and all were higher than our cohort ICU mortality of 18.4%.

All data published or reported, including ours, were preliminary and incomplete, representing up to 28 days post ICU admission. Consequently, all reported morality and LOS are likely underestimated. Although unable to compare admission acuity across cohorts and case series as APS and APACHE III scores were rarely reported, several factors can explain our lower mortality and LOS. First, the state of Ohio enacted early social distancing measures, school closures, and a "stay at home" order prevented a surge in COVID-19 infection and in ICU and hospital bed utilization. These measures allowed proper time for all health care systems to prepare, and none was overwhelmed with COVID-19 patients as was seen in other states such as New York and other countries such as Italy. In addition, we found a significantly lower rate of mechanical ventilation of 43.4% compared to most other cohorts and a lower median 7.0-day duration of mechanical ventilation compared to the 10 to 13.5 days reported in other studies [6, 7, 8] . Our planning and strict protocol-based best practice daily spontaneous breathing trial and sedation weaning also likely contributed to the result differences. Finally, as mentioned above, the date of data collection in June could have played a role in the observed reduction in ICU mortality since the start of the pandemic [11] . The main limitations of our study are the retrospective nature and use of data from a single health care system, which might restrict generalizability. However, this single system comprised 10 hospitals across Northeast Ohio, serving 2.7 million people. Our analysis of outcome data from more than 495 ICU patients with a 28-day follow-up is the fourth largest to be reported. Lower ICU and hospital LOS and mortality were noted compared to most other published cohorts and case series across the globe. Better preparedness and state-level control of preventive measures seem to be the most plausible explanations for the lower mortality and LOS. Future study should determine if the lower rate of mechanical ventilation use and shorter duration on mechanical ventilation played a role.

Future research is needed to further explain the higher mortality of COVID-19 viral pneumonia compared to other viral and community-acquired pneumonias and to explain differences in mortality and LOS at national and international levels across health care systems and over time.

No potential conflict of interest relevant to this article was reported.

World Health Organization. WHO coronavirus disease (COV-ID-19) dashboard [Internet]. Geneva: World Health Organization

Ohio Department of Health COVID-19 Dashboard

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with CO-VID-19 in the New York city area

Clinical course and risk factors for mortality of adult inpatients with COV-ID-19 in Wuhan, China: a retrospective cohort study

Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region

Covid-19 in critically ill patients in the Seattle region: case series

Factors associated with death in critically ill patients With coronavirus disease 2019 in the US

Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Clinical course and outcomes of 344 intensive care patients with COVID-19

Outcomes from intensive care in patients with COVID-19: a systematic review and metaanalysis of observational studies

Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state

Intensive Care National Audit and Research Centre. ICNARC report on COVID-19 in critical care

How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia

Diabetes surveillance system

Centers for Disease Control and Prevention